John Sensintaffar
Vanderbilt University · 89 works · 4,968 citations · h-index 23
Top works
- A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509
- Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures.
- Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts
- A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia
- BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90
- Rationally Designed High-Affinity 2-Amino-6-halopurine Heat Shock Protein 90 Inhibitors That Exhibit Potent Antitumor Activity
- 7‘-Substituted Benzothiazolothio- and Pyridinothiazolothio-Purines as Potent Heat Shock Protein 90 Inhibitors
- Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis
- Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods
- Orally Active Purine-Based Inhibitors of the Heat Shock Protein 90
- The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer
- Differential effects of flanking residues on presentation of epitopes from chimeric peptides
- A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors
- Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927
- Discovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors
- Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograft
- Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design
- Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer